96892 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa Toxoplasma
ANTIGENIC REGIONS FOR THE DETECTION OF ANTI-TOXOPLASMA GONDII IGM ANTIBODIES
#2TREATMENT AND DIAGNOSIS OF TOXOPLASMA-ASSOCIATED DISEASE
#3ENGINEERED PARASITES FOR DELIVERING PROTEIN TO THE CENTRAL NERVOUS SYSTEM (CNS)
#4Methods and compositions for assessing antibody specificities
#5Methods and compositions for assessing antibody specificities
#6METHODS AND COMPOSITIONS FOR ASSESSING ANTIBODY SPECIFICITIES
#7USE OF VIRUS-LIKE PARTICLES INCLUDING TOXOPLASMA GONDII APICAL MEMBRANE ANTIGEN 1 FOR SERODIAGNOSING TOXOPLASMOSIS
#8Pharmaceutical composition for preventing or treating inflammatory diseases including GRA9 protein or gene encoding the protein as active ingredient
#9Immunologically active fragments of toxoplasma gondii
#10Compositions and methods for regulation of chronic toxoplasma infection
#11Engineered parasites for delivering protein to the central nervous system (CNS)
#12Vaccine used for preventing toxoplasma gondii infection and preparation method therefor
#13Virus-like particles co-expressing IMC, ROP18, and MIC8, and pharmaceutical composition comprising the same
#14Methods and compositions for assessing antibody specificities
#15Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#16Engineered parasites for delivering protein to the central nervous system (CNS)
#17Methods and compositions for assessing antibody specificities
#18Methods and compositions for assessing antibody specificities
#19Methods and compositions for expressing functional class XIV myosin
#20Anticancer agent
#21Methods And Compositions Of Protein Antigens For The Diagnosis And Treatment Of Toxoplasma Gondii Infections And Toxoplasmosis
#22USE OF TOXOPLASMA GENE PRODUCTS TO PREVENT OR TREAT MICROBIAL INFECTIONS
#23CHIMERIC RECOMBINANT ANTIGENS OF TOXOPLASMA GONDII
#24USE OF A NEW ISOLATE OF NEOSPORA CANINUM FOR THE DEVELOPMENT OF DIAGNOSTIC TESTS AND FOR PREPARATION OF PRODUCTS FOR TREATMENT AND PREVENTION OF THE INFECTION CAUSED BY NEOSPORA
#25Novel Polypeptides Inducing Dendritic Cell Migration, as Well as Medicines and Pharmaceutical Compositions Containing Same
#26Construction of Recombinant Adenovirus With Genes That Codify for SAG1, SAG2 and SAG3
#27oocyst protein
#28Toxoplasma gondii Oocyst Protein
#29Chimeric recombinant antigens of
#30nucleic acid molecules
#31Detection of primary infections with pathogens
#32Polynucleotides encoding coccidian parasite casein kinase I, a chemotherapeutic target for antiprotozoal agents
#33Chimeric recombinant antigens of
#34Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof
#35Profilin and related immunomodulatory ligands
#36Antigen fragments for the diagnosis of Toxoplasma gondii
#37proteins
#38Polynucleotide encoding a genetically engineered P30 antigen
#39Toxoplasma gondii apical membrane antigen-1
#40Antigen fragments for the diagnosis of